One‑session bilateral radiofrequency thalamotomy to reduce medication‑resistant essential tremor
Official title: Simultaneous Bilateral Radiofrequency Thalamotomy for Medication-Refractory Essential Tremor
Run by Tokyo Women's Medical University · NCT07066358 · Data updated 2026-11-12
This trial will try a single‑session procedure that creates small lesions on both sides of the thalamus with radiofrequency energy to reduce disabling hand tremor in adults whose essential tremor has not improved with medicines.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 70 Years |
| Sex | All |
| Enrollment | 5 (estimated) |
| Sponsor | Tokyo Women's Medical University Academic / other |
| Locations | 1 site (Shinjuku-Ku, Tokyo) |
| Status | Recruiting |
| Started | July 3, 2025 |
| Main results expected | October 2026 |
| Study ends | December 2026 |
| Registry record updated | July 18, 2025 |
| Trial ID | NCT07066358 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 20 to 70 with neurologist‑diagnosed essential tremor that has not responded to standard medications, who can undergo MRI and meet cognitive (MMSE ≥27) and surgical fitness criteria, are ideal candidates.
✕Probably not a fit
People with bleeding tendencies, MRI contraindications or significant intracranial pathology, pregnant or breastfeeding individuals, those with cognitive impairment, or those whose tremor is controlled by medication are unlikely to benefit from this procedure.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single‑arm feasibility and safety trial enrolling five adults with medication‑refractory essential tremor. Participants will undergo stereotactic, simultaneous bilateral radiofrequency lesioning of the ventral intermediate nucleus (Vim) of the thalamus in a single operative session with MRI used for planning and intraoperative guidance. Preoperative clinical assessments and MRI are performed, and standardized tremor rating scales and follow‑up visits will monitor outcomes and adverse effects. The protocol focuses on short‑term safety (including speech, swallowing, and gait) and early efficacy for bilateral tremor suppression.
Why it matters
Potential benefit: If successful, the procedure could reduce tremor in both hands with a single operation, improving daily activities such as writing, eating, and dressing.
How similar studies have gone: Staged bilateral thalamotomies and MR‑guided focused ultrasound approaches have shown promising results, but simultaneous bilateral radiofrequency thalamotomy has been rarely studied and remains largely untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 20 to 70 years. * Diagnosis of essential tremor by a neurologist or neurosurgeon specializing in movement disorders. * Refractory to standard pharmacological therapy (e.g., propranolol, primidone, benzodiazepines, or alprenolol). * Mini-Mental State Examination (MMSE) score ≥ 27. * Able to undergo MRI. * Provided written informed consent for participation in the study. Exclusion Criteria: * History or evidence of bleeding tendency. * MRI contraindications (e.g., metallic implants, severe claustrophobia). * Presence of intracranial pathology on preoperative MRI that would interfere with surgery. * Pregnant or breastfeeding individuals. * Any other condition that the principal investigator deems inappropriate for study participation.
Where it's running
-
Tokyo Women's Medical University, Department of Neurosurgery
Shinjuku-Ku, Tokyo, Japan Recruiting
Study contacts
- Principal investigator: Shiro HORISAWA, MD — Tokyo Women's Medical University
- Study coordinator: SHIRO Horisawa, MD
- Email: neurosurgery0222@gmail.com
- Phone: +81333538111
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Encora X1 in Daily Life for Essential Tremor
This real-world study tests how the Encora X1 wrist device affects day-to-day activities for adults with essential tremor over three years.
-
Intraoperative Microelectrode Recordings with MAVEN vs Standard Equipment
This study tests whether MAVEN can match the recording data collected during DBS surgery for movement disorders using standard equipment.
-
Microelectrode-based brain stimulation for Parkinson’s and essential tremor
This early feasibility test checks a new microelectrode-based brain stimulation method in adults with Parkinson’s disease or essential tremor who are already getting deep brain stimulation implants.
-
Non-Invasive Nerve Stimulation for Essential Tremor: Long-Term Safety and Effectiveness
This study tests whether a non-invasive stimulation device called TAPS helps reduce tremor in adults with essential tremor over a long period.
-
Low Intensity Focused Ultrasound for Essential Tremor in Adults
This early-stage, open-label study tests whether repeated low-intensity focused ultrasound can safely and briefly modulate tremor in people with essential tremor.
-
Closed-loop TMS to reduce tremor
This trial tries phase-locked transcranial magnetic stimulation (TMS) to reduce tremor in people with essential tremor or Parkinson's disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.